Defining the Pharmaceutical System to Support Proactive Drug Safety

ISSN: 2212-3911 (Online)
ISSN: 1574-8863 (Print)


Volume 9, 3 Issues, 2014


Download PDF Flyer




Current Drug Safety

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Dr. Seetal Dodd
University of Melbourne
Geelong, 3220
Australia


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Defining the Pharmaceutical System to Support Proactive Drug Safety

Author(s): Vicki R. Lewis, Angelica Hernandez and Margaret Meadors

Affiliation: MedStar National Center for Human Factors in Healthcare, 3007 Tilden St. NW, Suite 7M, Washington, D.C. 20008, USA

Abstract

The military, aviation, nuclear, and transportation industries have transformed their safety records by using a systems approach to safety and risk mitigation. This article creates a preliminary model of the U.S. pharmaceutical system using available literature including academic publications, policies, and guidelines established by regulatory bodies and drug industry trade publications. Drawing from the current literature, the goals, roles, and individualized processes of pharmaceutical subsystems will be defined. Defining the pharmaceutical system provides a vehicle to assess and address known problems within the system, and provides a means to conduct proactive risk analyses, which would create significant pharmaceutical safety advancement.


Purchase Online Rights and Permissions

  
  



Article Details

Volume: 7
First Page: 1
Page Count: 1
DOI: 10.2174/15748863112079990004
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science